David P.L. Chan*† , Stephen C.B. Teoh*†‡, Colin S.H. Tan*†, Gerard K.M. Nah†‡, Rajesh Rajagopalan*, Manjunath K. Prabhakaragupta‡, Caroline K.L. Chee†‡, Tock H. Lim*†, Kong Y. Goh*†, and on behalf of The Eye Institute Dengue-Related Ophthalmic Complications Workgroup
Author affiliations: *The Eye Institute at Tan Tock Seng Hospital, Republic of Singapore; †Singapore National Eye Research Institute, Singapore; ‡The Eye Institute at National University Hospital, National University Hospital, Singapore
Figure A1. Summary of patient demographics, manifestations, clinical findings, management, and outcome. DF, dengue fever; DHF , dengue hemorrhagic fever; NA, not available; BOV, blurring of vision; VA, visual acuity (Snellen); OU, both eyes; OD, right eye; OS, left eye.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.